These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1288 related articles for article (PubMed ID: 19719418)

  • 21. [Antibacterial activity of tobramycin].
    Acar JF
    Nouv Presse Med; 1974 Apr; 3(0):57-9. PubMed ID: 4600179
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chemo-antibiotico-therapy today. I].
    Cairella M; Marasa G
    Clin Ter; 1974 Jun; 69(6):561-84. PubMed ID: 4845638
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimicrobial resistance and extinction.
    Desikan P
    Indian J Med Microbiol; 2011; 29(3):207-8. PubMed ID: 21860097
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibacterial antibiotics. Classification, principles and utilization rules].
    Bergogne-Bérézin E
    Rev Prat; 1998 May; 48(9):991-7. PubMed ID: 11767360
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antibacterial therapy and the prevention of acute pyelonephritis and its complications].
    Ezdokian AS; Ukhin AV
    Urol Nefrol (Mosk); 1989; (1):70-4. PubMed ID: 2655255
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bacteriological characteristics of intrahospital infections in urological patients].
    Sarkulova MN
    Urologiia; 2006; (1):19-22. PubMed ID: 16550817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The possibilities for the bacteriology laboratory in guiding antibiotic therapy].
    Turcu T
    Rev Med Chir Soc Med Nat Iasi; 1988; Suppl():51-6. PubMed ID: 3253912
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibacterial preparations against nonsporulating anaerobic bacteria].
    Oleĭnik II; Bychenko BD; Robustova TG; Zhdanov LP
    Antibiotiki; 1984 Aug; 29(8):619-28. PubMed ID: 6385833
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibacterial resistance: is there a way out of the woods?
    Marra A
    Future Microbiol; 2011 Jul; 6(7):707-9. PubMed ID: 21797683
    [No Abstract]   [Full Text] [Related]  

  • 30. [Progress in antibacterial therapy].
    Dimitriu SM
    Rev Med Chir Soc Med Nat Iasi; 1988; Suppl():15-25. PubMed ID: 3075795
    [No Abstract]   [Full Text] [Related]  

  • 31. [Theoretical and practical significance of resistance of the urinary bacterial flora to chemoantibiotics].
    Porta F; Romero E
    Quad Sclavo Diagn; 1972 Dec; 8(4):1111-22. PubMed ID: 4668734
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibiotic resistance: understanding how to control it.
    Gould IM
    Int J Antimicrob Agents; 2012 Sep; 40(3):193-5. PubMed ID: 22824370
    [No Abstract]   [Full Text] [Related]  

  • 33. Selecting empiric antibiotic therapy in an era of multi-drug resistance--is the cupboard really bare? Introduction.
    Collatz E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():1. PubMed ID: 19040460
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathogenic bacteria: how to get them back into the line of fire?
    Keck W; Hubschwerlen C
    Curr Opin Investig Drugs; 2005 Feb; 6(2):139-40. PubMed ID: 15751735
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacterial sensitivity to chemotherapeutic agents (Zurich, 1990)].
    Wüst J; Kayser FH
    Schweiz Rundsch Med Prax; 1991 Sep; 80(37):946-53. PubMed ID: 1925214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bases for antibacterial treatment].
    Katranushkova N
    Akush Ginekol (Sofiia); 1979; 18(6):437-44. PubMed ID: 525722
    [No Abstract]   [Full Text] [Related]  

  • 37. Détente in the war against bugs.
    Schelonka RL
    Pediatr Infect Dis J; 2007 Jul; 26(7):600-1. PubMed ID: 17596801
    [No Abstract]   [Full Text] [Related]  

  • 38. [STRATEGY OF ANTIBACTERIAL THERAPY OF SEPSIS. PART I].
    Shapoval SD; Savon IL; Martyniuk VB; Vasylevska LA; Yakunych AM; Maksimova OO; Sofilkanych MM
    Klin Khir; 2015 Jun; (6):62-6. PubMed ID: 26521472
    [No Abstract]   [Full Text] [Related]  

  • 39. [Plectasin - a new peptide antibiotic with high therapeutic potential].
    Schmitz J; Holzgrabe U
    Pharm Unserer Zeit; 2010 Sep; 39(5):336-8. PubMed ID: 20818681
    [No Abstract]   [Full Text] [Related]  

  • 40. Selection of antibiotic-resistant pathogens in the community.
    Yagupsky P
    Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.